Injectable Drug Delivery Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
- 99S4095609
- 130 Pages
- November 2020
- Healthcare
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary
.
The global Injectable Drug Delivery market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Injectable Drug Delivery market segmented into
Aesthetics
Antibiotics
Immunosuppressive Agents
Antihypertensive Agents
Based on the end-use, the global Injectable Drug Delivery market classified into
Aesthetics
Autoimmune Diseases
Hormonal Disorders
Infectious Diseases
Oncology
Pain Management
Based on geography, the global Injectable Drug Delivery market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Becton
Dickinson and Company
Baxter International
Gerresheimer
Pfizer
Schott
Sandoz
Teva Pharmaceutical Industries
Eli Lilly and Company
Antares Pharma
Eli Lilly & Company
Hospira
Novo Nordik
Sanofi
Terumo Corporation
Unilife Corporation
Zogenix
Scandinavian Health
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL INJECTABLE DRUG DELIVERY INDUSTRY
2.1 Summary about Injectable Drug Delivery Industry
2.2 Injectable Drug Delivery Market Trends
2.2.1 Injectable Drug Delivery Production & Consumption Trends
2.2.2 Injectable Drug Delivery Demand Structure Trends
2.3 Injectable Drug Delivery Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Analgesics
4.2.2 Antibiotics
4.2.3 Immunosuppressive Agents
4.2.4 Antihypertensive Agents
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Aesthetics
4.3.2 Autoimmune Diseases
4.3.3 Hormonal Disorders
4.3.4 Infectious Diseases
4.3.5 Oncology
4.3.6 Pain Management
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Analgesics
5.2.2 Antibiotics
5.2.3 Immunosuppressive Agents
5.2.4 Antihypertensive Agents
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Aesthetics
5.3.2 Autoimmune Diseases
5.3.3 Hormonal Disorders
5.3.4 Infectious Diseases
5.3.5 Oncology
5.3.6 Pain Management
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Analgesics
6.2.2 Antibiotics
6.2.3 Immunosuppressive Agents
6.2.4 Antihypertensive Agents
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Aesthetics
6.3.2 Autoimmune Diseases
6.3.3 Hormonal Disorders
6.3.4 Infectious Diseases
6.3.5 Oncology
6.3.6 Pain Management
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Analgesics
7.2.2 Antibiotics
7.2.3 Immunosuppressive Agents
7.2.4 Antihypertensive Agents
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Aesthetics
7.3.2 Autoimmune Diseases
7.3.3 Hormonal Disorders
7.3.4 Infectious Diseases
7.3.5 Oncology
7.3.6 Pain Management
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Analgesics
8.2.2 Antibiotics
8.2.3 Immunosuppressive Agents
8.2.4 Antihypertensive Agents
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Aesthetics
8.3.2 Autoimmune Diseases
8.3.3 Hormonal Disorders
8.3.4 Infectious Diseases
8.3.5 Oncology
8.3.6 Pain Management
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Analgesics
9.2.2 Antibiotics
9.2.3 Immunosuppressive Agents
9.2.4 Antihypertensive Agents
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Aesthetics
9.3.2 Autoimmune Diseases
9.3.3 Hormonal Disorders
9.3.4 Infectious Diseases
9.3.5 Oncology
9.3.6 Pain Management
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Becton
10.1.2 Dickinson and Company
10.1.3 Baxter International
10.1.4 Gerresheimer
10.1.5 Pfizer
10.1.6 Schott
10.1.7 Sandoz
10.1.8 Teva Pharmaceutical Industries
10.1.9 Eli Lilly and Company
10.1.10 Antares Pharma
10.1.11 Eli Lilly & Company
10.1.12 Hospira
10.1.13 Novo Nordik
10.1.14 Sanofi
10.1.15 Terumo Corporation
10.1.16 Unilife Corporation
10.1.17 Zogenix
10.1.18 Scandinavian Health
10.2 Injectable Drug Delivery Sales Date of Major Players (2017-2020e)
10.2.1 Becton
10.2.2 Dickinson and Company
10.2.3 Baxter International
10.2.4 Gerresheimer
10.2.5 Pfizer
10.2.6 Schott
10.2.7 Sandoz
10.2.8 Teva Pharmaceutical Industries
10.2.9 Eli Lilly and Company
10.2.10 Antares Pharma
10.2.11 Eli Lilly & Company
10.2.12 Hospira
10.2.13 Novo Nordik
10.2.14 Sanofi
10.2.15 Terumo Corporation
10.2.16 Unilife Corporation
10.2.17 Zogenix
10.2.18 Scandinavian Health
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
1.Table Injectable Drug Delivery Product Type Overview
2.Table Injectable Drug Delivery Product Type Market Share List
3.Table Injectable Drug Delivery Product Type of Major Players
4.Table Brief Introduction of Becton
5.Table Brief Introduction of Dickinson and Company
6.Table Brief Introduction of Baxter International
7.Table Brief Introduction of Gerresheimer
8.Table Brief Introduction of Pfizer
9.Table Brief Introduction of Schott
10.Table Brief Introduction of Sandoz
11.Table Brief Introduction of Teva Pharmaceutical Industries
12.Table Brief Introduction of Eli Lilly and Company
13.Table Brief Introduction of Antares Pharma
14.Table Brief Introduction of Eli Lilly & Company
15.Table Brief Introduction of Hospira
16.Table Brief Introduction of Novo Nordik
17.Table Brief Introduction of Sanofi
18.Table Brief Introduction of Terumo Corporation
19.Table Brief Introduction of Unilife Corporation
20.Table Brief Introduction of Zogenix
21.Table Brief Introduction of Scandinavian Health
22.Table Products & Services of Becton
23.Table Products & Services of Dickinson and Company
24.Table Products & Services of Baxter International
25.Table Products & Services of Gerresheimer
26.Table Products & Services of Pfizer
27.Table Products & Services of Schott
28.Table Products & Services of Sandoz
29.Table Products & Services of Teva Pharmaceutical Industries
30.Table Products & Services of Eli Lilly and Company
31.Table Products & Services of Antares Pharma
32.Table Products & Services of Eli Lilly & Company
33.Table Products & Services of Hospira
34.Table Products & Services of Novo Nordik
35.Table Products & Services of Sanofi
36.Table Products & Services of Terumo Corporation
37.Table Products & Services of Unilife Corporation
38.Table Products & Services of Zogenix
39.Table Products & Services of Scandinavian Health
40.Table Market Distribution of Major Players
41.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
42.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
43.Table Global Injectable Drug Delivery Market Forecast (Million USD) by Region 2021f-2026f
44.Table Global Injectable Drug Delivery Market Forecast (Million USD) Share by Region 2021f-2026f
45.Table Global Injectable Drug Delivery Market Forecast (Million USD) by Demand 2021f-2026f
46.Table Global Injectable Drug Delivery Market Forecast (Million USD) Share by Demand 2021f-2026f
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
